fox files

Taxpayer-Funded Scientists Create Human Bird Flu Virus in Georgia BSL-3 Lab That Successfully Crosses Species

USDA, NIAID, and NIH finance genetic experiment generating human avian influenza pathogen from scratch that can infect cows.

A newly published study in npj Veterinary Sciences reveals that federally funded researchers have bioengineered an infectious human H5N1 bird flu pathogen in a Biosafety Level 3 (BSL-3) laboratory and intentionally infected dairy cows.

The new bird flu project received backing from the U.S. Department of Agriculture (USDA), the National Institutes of Health (NIH), and the National Institute of Allergy and Infectious Diseases (NIAID).

According to the study:

“Reverse genetics plasmids for wild-type A/Texas/37/2024 (H5N1)… were obtained from Twist Biosciences.”

“Reverse genetics to generate the infectious clone was performed using the 8-plasmid system… in a Biosafety Level 3 (BSL-3) laboratory.”

Using plasmid-based biotechnology, researchers say they have built a live infectious clone of a human H5N1 bird flu virus inside a federally funded high-containment laboratory.

You can contact NIAID here, the NIH here, HHS here, and the USDA here to voice opposition to taxpayer-funded research on pandemic pathogens—particularly after Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) all acknowledged that the deadly COVID-19 pandemic was “likely” the result of a laboratory incident involving genetically engineered pathogens.

The study’s listed researchers from the University of Georgia (contact) are: Flavio Cargnin Faccin, L. Claire Gay, Dikshya Regmi, Sasha Compton, Teresa D. Mejías, Juliana Calil Brondani, Lok R. Joshi, Elizabeth W. Howerth, Daniela S. Rajao, Roberto A. Palomares, and Daniel R. Perez.

---

Scientists Directly Infect Live Dairy Cows

After constructing the pathogen, researchers deliberately exposed cows through both nasal and direct mammary gland infection:

“Cows were inoculated with 1 × 106 TCID50/ml of A/Texas/37/2024 (H5N1), administered as follows: 4 ml instilled into each nostril… and 2 ml in each of two quarters… using a teat cannula.”

Scientists directly introduced the bioengineered virus into cows’ noses and milk-producing udder tissue.

Infection Triggers Severe Biological Damage

Following deliberate infection:

• Milk production collapsed by roughly 75%
• Milk became yellow and abnormal
• Mammary glands developed severe mastitis and tissue destruction
• Viral replication surged in milk and udder tissue
• Fever spike reached 106°F

Researchers report:

“Milk production rapidly decreased, and milk samples exhibited a colostrum-like appearance.”

“These findings strongly support significant viral replication within infected quarters.”

Human Bird Flu Crosses Directly Into Cattle

Researchers confirm:

“By using a human H5N1 virus, we demonstrated that cows could be infected with a human H5N1 strain.”

Backed by NIH, NIAID, and USDA funding, scientists successfully bioengineered an infectious human H5N1 bird flu virus and demonstrated that it can cross species barriers and infect large mammalian livestock.

Federal Bird Flu Infrastructure Expands Vaccine Development

Researchers explicitly state:

“Our findings confirm that Jersey cows are susceptible to H5N1 infection and establish them as a valuable experimental model for studying disease pathogenesis and vaccine development.”

Federal agencies now expand dairy cattle as a large-animal model for future H5N1 vaccine development and pathogenesis programs.

Federal Funding Streams

Funding includes:

• USDA/NIFA
• NIH/NIAID
• Federal contracts
• Government influenza grants

“We thank Julia Grindle and Kilie Wilson for their assistance with milking the cows during the acclimation period. We thank Jazmin Destiny Lynn, Hannah Walker, Karly Pecua, Morgan George, and Robert Gafnea at the Animal Health and Research Center, University of Georgia, specifically for their assistance during animal studies under Animal Biosafety Level 3 containment. Funding for this work includes grants, contracts, and subawards to D.R.P. including National Institute of Food and Agriculture (NIFA), U.S. Department of Agriculture (USDA) Grant award numbers 2020-67015-31539 and 2021-67015-33406, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) Grant award number R21AI146448 and R01AI154894, Contract number 75N93021C00014 and Options 15A, 15B and 17A. Additional funds were provided to D.R.P. by the Georgia Research Alliance and the Caswell S Eidson Chair in Poultry Medicine endowment funds.”

Bottom Line

USDA, NIH, and NIAID actively fund scientists to build a bioengineered human H5N1 bird flu pathogen in a BSL-3 laboratory, prove it can cross species barriers into large mammalian livestock, and deliberately infect dairy cows to expand federal bird flu pathogenesis and vaccine development infrastructure.

The study confirms U.S. government-backed scientists are not only constructing and deploying infectious bird flu pathogens in live animals, but also expanding the biological and operational systems needed for future large-scale influenza experimentation, surveillance, and countermeasure development.

USDA/NIAID-Funded Scientists Build Chimeric Bird Flu Viruses with 100% Mortality in Mammals: Journal ‘npj Vaccines’

Gov’t finances creation of lethal avian influenza Frankenviruses in Nebraska.

A newly released npj Vaccines study confirms that U.S. government–funded researchers constructed hybrid influenza viruses in the lab and used them to trigger complete mortality in animal experiments, while framing the work under vaccine development.

The experiment, titled “Dual-Route H5N1 Vaccination Induces Systemic and Mucosal Immunity in Murine and Bovine Models,” was conducted by University of Nebraska–Lincoln scientists Joshua Wiggins, Adthakorn Madapong, and Eric A. Weaver.

You can contact the university’s Center for Virology here and the School of Biological Sciences here.

The creation of deadly chimeric pathogens was financed by the U.S. Department of Agriculture (USDA) and the National Institute of Allergy and Infectious Diseases (NIAID).

The study explicitly states:

“This research was supported by the U.S. Department of Agriculture, National Institute of Food and Agriculture, Agriculture and Food Research Initiative (Grant Nos. 2020 -06448 and 2024 -08723 to E.A.W.), and by the National Institutes of Health –NIAID (Grant No. 1R01AI147109 to E.A.W.).”

You can contact NIAID here, the NIH here, HHS here, and the USDA here to voice opposition to taxpayer-funded chimeric research on pandemic pathogens—particularly after Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) all acknowledged that the deadly COVID-19 pandemic was “likely” the result of a laboratory incident involving genetically modified pathogens.

---

Lab-Built ‘Chimeric’ Influenza Viruses

The researchers say they constructed the hybrid bird flu pathogens using reverse genetics.

That means the scientists assembled the viruses from scratch by inserting their genetic sequences into plasmids and introducing them into cells, which then are said to produce a fully formed infectious virus.

The paper states:

“A BSL-2 compliant reverse genetic (rg) system was used to produce” H5N1 Influenza A virus strains.”

And details how they were assembled:

“Six (PB1, PB2, PA, NP, M, and NS) IAV gene segments from the PR/8/34 H1N1 laboratory strain were cloned individually into the pHW2000 vector. Separately, the neuraminidase (N) gene and hemagglutinin (H) gene without the highly pathogenic multibasic cleavage site from each strain were synthesized and cloned into the same pHW2000 vector.”

This is a genetic recombination system:

• Internal genes from a lab strain (PR/8/34)
• Surface genes (H5N1) inserted
• Entire virus rebuilt from plasmids

That is a chimeric influenza construct—a hybrid assembled in the lab.

Engineered Pathogens Cause Lethal Disease

Even with deliberate modification of a known virulence element:

“hemagglutinin… without the highly pathogenic multibasic cleavage site”

—the viruses remained lethal.

100% Mortality in Mammals

The outcome in animals exposed to these engineered viruses is stated plainly:

“unvaccinated DPBS controls exhibited progressive weight loss… reaching 25%… requiring euthanasia.”

And:

“all control mice succumbed to infection.”

In contrast to any other framing, this is the core biological result:

• Rapid disease progression
• Severe physiological decline
• Complete mortality in unprotected animals

‘Lethal Challenge’ With Lab-Constructed Viruses

The study confirms the conditions:

“mice were challenged with lethal H5N1 reverse genetics (rg)-A/Vietnam/1203/2004(Vietnam/1203/04) or rg-A/Bovine/Ohio/B24-OSU-439/2024 (Bovine/24).”

The animals were intentionally infected with engineered lethal influenza hybrid constructs.

What the Study Actually Demonstrates

Stripped of framing, the paper shows:

• U.S. government–funded researchers
• Constructed hybrid (chimeric) influenza viruses from genetic components
• Used those constructs to induce lethal disease in mammals
• Achieved 100% mortality in controls under experimental infection

The work is presented under the justification of vaccine research.

But the underlying capability demonstrated is the intentional assembly and use of bioengineered influenza pathogens capable of killing animals.

Bottom Line

NIAID- and USDA-funded researchers say they built lab-assembled bird flu viruses by combining genetic components from multiple strains.

Then they used those engineered pathogens to infect mammals, producing rapid disease and 100% death.

Washington Joins WHO Pandemic Orchestration and Surveillance Network ‘GOARN’—Citing Bird Flu as Justification

Follows California, Illinois, Colorado, and New York City’s entry into same transnational WHO outbreak coordination system.

Governor Bob Ferguson announced this month that Washington State is now part of the World Health Organization Global Outbreak and Response Network (GOARN), an international syndicate of “public health agencies, national governments, academic centers, laboratories, and response organizations focused on rapidly detecting and responding to public health emergencies,” according to a press release from the Washington State Nurses Association (WSNA).

Washington joins California, Illinois, Colorado, and New York City by entering GOARN.

According to WSNA, Washington’s public health leaders will fall in line with the WHO’s:

• global outbreak early-warning alerts, meaning real-time surveillance tied into an international detection system
• technical collaboration and support during major public health events, meaning coordinated response across jurisdictions
• international training, exercises, and best-practice exchanges, meaning standardized response protocols
• and coordinated outbreak response support, meaning integrated deployment during declared emergencies.

Congress has already confirmed that the WHO’s response to the COVID-19 pandemic “was an abject failure” and that the WHO’s “newest effort to solve the problems exacerbated by the COVID-19 pandemic — via a “Pandemic Treaty” — may harm the United States.”

This means Washington’s decision comes despite federal findings that the WHO mismanaged the last pandemic and is advancing new agreements that could expand its influence over future responses.

You can contact Gov. Ferguson’s office here to voice your opposition to Washington’s integration into a WHO-linked outbreak surveillance and response system and demand accountability for aligning state public health infrastructure with failed global coordination mechanisms.

Washington State Governor Bob Ferguson (Governor.WA.gov)

In the governor’s press release, Washington State Secretary of Health Dennis Worsham cited avian influenza (“bird flu”) in justifying the move:

“Disease outbreaks don’t stop at state or national borders, and our ability to protect people in Washington shouldn’t either,” Washington State Secretary of Health Dennis Worsham said. “Joining GOARN ensures we maintain access to critical global outbreak intelligence and stay connected to leading public health experts, even as federal relationships change. We’re not waiting for the next threat — we’re preparing for it. From COVID-19 to rising measles cases and avian influenza, we’ve seen how quickly diseases can spread. Through GOARN, we can detect risks earlier, respond faster and better protect people in our communities — while also contributing Washington’s expertise to global response efforts.”

The development comes as bird flu is being framed internationally as an imminent threat while laboratory manipulation of the virus continues, vaccines are developed in parallel, and global, federal, and state systems are aligned to respond.

This is the same sequence of surveillance, lab work, and countermeasure rollout that preceded the COVID-19 pandemic.

Massachusetts Advances H5N1 Influenza Bird Flu Bill with Quarantine Protocols, Surveillance Grid, and Vaccination Strategies

Lawmakers move avian influenza response infrastructure into study pipeline while preserving full operational framework.

A Massachusetts bill laying out a full-scale response system for H5N1 avian influenza “bird flu” is advancing through the legislature—constructing quarantine protocols, mass surveillance systems, vaccine deployment planning, and statewide clinical trial infrastructure around a single named virus before any declared widespread outbreak.

The move comes as state, federal, and international actors are orchestrating the systems, infrastructure, and response mechanisms surrounding a future bird flu pandemic.

Massachusetts House Bill 2385 (H2385), introduced February 27, 2025 by Representative Leigh Davis (D-3rd Berkshire), does not address general pandemic preparedness.

Instead, it is specifically targeted at H5N1 bird flu, directing the state to build a coordinated response system spanning human, livestock, and wildlife populations under a single-disease framework.

On March 16, 2026, lawmakers moved the bill into a Public Health study order (H5234), advancing the proposal into a formal development phase—preserving the full framework while removing it from an immediate vote.

After sitting untouched for over a year, the bill was suddenly acted on and moved into a study process—signaling it had become important enough to preserve and develop, but not yet ready to pass in its current form.

You can contact Rep. Davis’ office here and the rest of the Massachusetts representatives here to voice your opinion on the bill.

---

Emergency Bird Flu Powers Activated Up Front

The bill opens with emergency language:

“declared to be an emergency law, necessary for the immediate preservation of the public health.”

This positions the H5N1 response system for rapid activation, not gradual implementation.

Mass Bird Flu Surveillance Across Humans & Animals

The bill directs:

“developing surveillance programs to detect and track outbreaks of H5N1 in wildlife, poultry, dairy cattle and humans”

This creates a multi-species surveillance system focused specifically on bird flu, linking:

• agricultural environments
• wildlife reservoirs
• human cases

into a centralized tracking network.

Quarantine & Vaccine Plans Pre-Built for H5N1

The commission is tasked with designing:

“emergency response plans… including quarantine measures, vaccination strategies”

This establishes predefined intervention mechanisms, including:

• quarantine and isolation protocols
• movement restrictions tied to exposure
• coordinated vaccine deployment strategies

—all built specifically around bird flu response.

Statewide Bird Flu Trials Ready for Rapid Deployment

The bill calls for:

“preparation to launch statewide clinical trials that swiftly evaluate… novel therapeutic approaches”

This enables:

• rapid testing of treatments during an H5N1 event
• deployment of experimental or emerging interventions
• statewide scaling of trials

Farm Testing Network Expands Bird Flu Detection

The legislation includes:

“production of self-administered swabs… distributed to farms… allowing workers to… screen themselves”

This creates a continuous testing system tied directly to bird flu monitoring in:

• farms
• livestock environments
• worker populations

Drug Stockpiles Expand as Bird Flu Mutation Expected

The bill directs:

“shoring up of stockpiles… beyond Tamiflu… guard against viruses mutating”

This anticipates:

• mutation of H5N1
• purported need for expanded pharmaceutical reserves
• long-term treatment preparedness tied to bird flu

Private Funding Flows Into Bird Flu Response System

The commission is authorized to receive:

“funds from public and private sources such as gifts, grants and donations.”

This integrates:

• private funding sources
• external organizations
• non-government actors

into state bird flu response infrastructure.

Centralized Control System Coordinates Bird Flu Response

The bill mandates:

“coordinating efforts among government agencies… public health entities”

This establishes a centralized response model specifically for bird flu, aligning:

• public health agencies
• agriculture
• research institutions

Bill Quietly Advanced Into Study Pipeline Without Vote

The proposal remains active:

• Folded into study order H5234
• Discharged from Public Health Committee
• Transferred to the House Rules Committee

This keeps the full H5N1-focused framework moving through the legislative pipeline, positioning it for future action.

Bottom Line

H2385 is not a general preparedness bill.

It builds a targeted operational framework around avian influenza (H5N1) specifically.

The bill establishes:

• A bird flu surveillance grid across humans, livestock, and wildlife
• Predefined quarantine and vaccination protocols tied to H5N1
• A statewide clinical trial system ready for deployment
• A continuous testing pipeline in agricultural settings
• Expanded drug stockpiling anticipating mutation
• A public-private funding structure embedded in response planning
• A centralized command system for coordinated bird flu response

Lawmakers have now moved this framework into a formal study process—keeping it active and positioning it for future rollout.

China Conducts mRNA Influenza Bird Flu Vaccine Trials in Dairy Cows: Journal ‘Research’

Government preparation for large-scale mRNA vaccination of livestock.

Chinese government–funded researchers have confirmed that they tested an mRNA bird flu vaccine in lactating dairy cows, injecting milk-producing livestock with an mRNA–lipid nanoparticle formulation and then deliberately exposing the animals to live H5N1 influenza virus inside high-containment laboratories.

The peer-reviewed study published on Monday, in the journal Research, is titled “Protective Efficacy of a Hemagglutinin-Based mRNA Vaccine Against H5N1 Influenza Virus Challenge in Lactating Dairy Cows.”

The experiment signals that governments are actively preparing mRNA platforms for potential large-scale use in livestock populations, extending mRNA deployment beyond humans and into the food supply.

---

mRNA Vaccine Administered to Food-Producing Animals

According to the study, researchers injected an mRNA vaccine into lactating Holstein dairy cows, meaning animals actively producing milk.

The authors write:

“Six healthy lactating dairy cows were intramuscularly immunized with 500 μg of the mRNA vaccine twice, with a 3-week interval between doses.”

The animals were sourced from an external farm:

“Lactating Holstein cows, 3 to 5 years of age, obtained from a local dairy farm, were used in the challenge experiment.”

The vaccine was an mRNA–lipid nanoparticle (mRNA–LNP) formulation encoding the hemagglutinin protein of an avian influenza virus:

“We developed a monovalent, cattle-codon-optimized mRNA–LNP vaccine encoding the HA protein.”

Deliberate Infection with H5N1 Pathogen

After receiving the mRNA injections, both vaccinated and unvaccinated cows were moved into animal biosafety level 3+ (ABSL-3+) laboratories and deliberately infected with a purportedly live H5N1 influenza virus.

The paper states:

“3 vaccinated and 3 unvaccinated lactating dairy cows were transferred into the animal biosafety level 3+ (ABSL-3+) facility for the challenge study.”

The virus was said to be administered through multiple routes, including direct injection into the mammary glands:

“All cows received a DC/24 virus challenge administered via both the intranasal and intramammary routes.”

The authors further specify:

“3 doses were directly inoculated into separate mammary quarters via the teat.”

High-Containment Facilities & Lab-Generated Viruses

All work involving the pathogen was performed inside Chinese state-authorized high-containment laboratories.

The methods section states:

“The procedures involving live HPAI viruses were performed within certified BSL-3 and ABSL-3+ laboratories at the Harbin Veterinary Research Institute (HVRI), Chinese Academy of Agricultural Sciences (CAAS).”

The H5N1 viruses used were not simple field samples but laboratory-generated strains.

The authors cite a prior peer-reviewed study for the virus’s creation and laboratory handling methods, rather than detailing the generation process in this paper.

“The challenge dairy cow H5N1 virus (DC/24)… was generated as previously described.”

Chinese Government Funding

The study was funded entirely by Chinese state and government research programs.

The funding disclosure reads:

“This research was funded by the National Key Research and Development Program of China… the National Natural Science Foundation of China… the Innovation Program of the CAAS… the natural science foundation of Heilongjiang Province… [and] the Central Public Interest Scientific Institution Basal Research Fund.”

All authors are affiliated with Chinese government research institutes or state-linked laboratories, including the Chinese Academy of Agricultural Sciences and China’s National High Containment Laboratory for Animal Disease Control and Prevention.

Bottom Line

The paper confirms that China is now testing mRNA vaccine platforms directly in livestock, including milk-producing animals, using live avian influenza viruses under high-containment laboratory conditions.

The study documents the use of modern mRNA technology not only in humans or laboratory animals, but in food-supply species that interface directly with agriculture, trade, and public health systems.

NIAID Funds Gain-of-Function Study Engineering Novel Influenza Viruses With New Mammalian Pathogenic and Host-Entry Functions: Journal ‘Emerging Microbes & Infections’

Despite claims the U.S. has stopped bankrolling gain-of-function experiments.

A new peer-reviewed study published this week states that federally funded researchers genetically engineered viruses that gained biological functions not present in any naturally occurring strain, including new host-entry mechanisms, cross-species antigen display, and mammalian lethality.

In multiple cases, viral surface proteins from one species and virus family were deliberately inserted into the genetic backbone of an entirely different virus, creating laboratory chimeras that bridge species and viral lineages that do not naturally mix.

The paper, “Immunogenicity and Efficacy of a Rabies-Based Vaccine against Highly Pathogenic Influenza H5N1 Virus,” appears in Emerging Microbes & Infections.

The study documents three distinct categories of functional gain:

1. transfer of influenza entry machinery into foreign viral backbones,
2. reprogramming of rabies virus to perform influenza functions, and
3. creation of new influenza chimeras that are lethal in mammals.

(Editor’s note: This article makes no claims about virology and/or terrain theory. It is reporting what NIAID-funded scientists claim to be doing with American taxdollars.)

Funding & Research Sites

The authors state:

“This study was supported by… the Center for Research on Influenza Pathogenesis and Transmission (CRIPT), one of the National Institute of Allergy and Infectious Diseases (NIAID) funded Centers of Excellence for Influenza Research and Response (CEIRR; contract # 75N93021C00014), and by NIAID contract SEM-CIVIC (contract number 75N93019C00051).”

NIAD is under the control of Director Jeffery Taubenberger, who is directing U.S. taxdollars toward influenza gain-of-function experiments while holding a patent for an influenza vaccine at the center of the Trump administrations $500 million influenza vaccine program.

This raises national security and conflict of interest concerns, as it represents the simultaneous creation of a lucrative problem and solution.

NIAD is under the authority of U.S. Health and Human Services (HHS), which is led by Robert F. Kennedy Jr.

Animal experiments were approved under:

“the Institutional Animal Care and Use Committee (IACUC) of Thomas Jefferson University (TJU).”

Influenza Host-Entry Functions Transferred Into a Different Virus

The authors state that they created a vesicular stomatitis virus whose native entry protein was replaced with influenza H5:

“VSV∆G-H5-GFP encoding either the clade 1 H5 (A/Viet Nam/1203/2004(H5N1) or the circulating clade 2.3.4.4b cow was generated as described.”

This describes a virus that now uses influenza hemagglutinin to enter host cells—a function VSV does not naturally possess.

It also represents a direct cross-species and cross-virus transfer of host-entry machinery, merging an avian influenza protein with a livestock-associated strain and a human-infecting viral backbone in a single engineered system.

Rabies Virus Reprogrammed to Display & Deliver Influenza Antigen

The study confirms that a rabies virus was engineered to express influenza H5:

“We developed a rabies virus-based H5 vaccine (RABV-H5) by insertion of a synthetic full-length codon-optimized HA ORF of the Influenza virus A/Vietnam 1203/2004(H5N1) into the BNSP333 rabies vaccine vector between the N and P genes.”

The authors further state:

“Presenting both RABV-G and the antigen of choice on the surface.”

This confirms that a neurotropic virus was genetically modified to perform a new influenza-specific function.

The lab construct combines a mammalian neurotropic virus with an avian influenza surface antigen, creating a synthetic cross-species hybrid that does not exist in nature.

Creation of Novel Influenza Viruses That Did Not Exist in Nature

The paper says that new influenza viruses were constructed by genome segment replacement:

“PR8-H5N1, a recombinant Puerto-Rico 8 influenza A virus (A/PR8) in which the HA and NA genomic segments have been replaced with the respective segments of H5N1.”

A second engineered virus is identified:

“Influenza virus A/PR8-H5N1 bovine/Ohio/439/2024 (2024).”

These viruses did not exist prior to laboratory construction.

Engineered Viruses Demonstrated Mammalian Pathogenicity

The authors report intranasal infection of mice with the engineered viruses:

“On days 104 or 150, mice were challenged by IN instillation with 0.05 ml of either 1E5 TCID50 of Influenza A/PR8-H5N1 (Viet Nam 1203 or Cow) or with 100 pfu of HPAI-H5N1 Viet Nam 1203 (2004) diluted in PBS+1% heat-inactivated FBS.”

They further confirm the dose was lethal:

“[O]n day 104 were challenged by IN instillation with a 1E5 pfu lethal dose of A/PR8-H5N1 Viet Nam 1203 virus (>100LD50).”

The paper documents viral replication in lungs:

“While unvaccinated mice had about 1E6 TCID50/ml of replicating virus in the lungs.”

And describes lung pathology:

“Severe and chronic bronchiolocentric infection with bronchiolar and peribronchiolar infiltration of lymphocytes, associated with interstitial pneumonitis and expanded alveolar wall due to edema and inflammation.”

Bottom Line

The new study makes clear that gain-of-function virus creation is allegedly still being carried out with U.S. taxpayer dollars, despite the national security and biosafety risks such work poses to the very population funding it.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

Why does the U.S. continue to fund the same experiments that are said to have caused the last pandemic?

June 19, 2025

Read full story

NIAID Director Holds Patent for Bird Flu Pandemic Vaccine—as His Agency Creates Frankenstein Bird Flu Viruses in the Lab

October 10, 2025

Read full story

Bird Flu Takes Central Role in Trump Admin’s New $500 Million ‘Next-Generation’ Pandemic Vaccine Project

May 2, 2025

Read full story

USDA–Iowa State University Lab-Engineer New Chimeric Bird Flu Viruses That Bind to Human Breast Tissue: ‘Journal of Dairy Science’

November 30, 2025

Read full story

USDA–NIH–University of Georgia–Mount Sinai Team Aerosolizes Lab-Engineered ‘Chimeric’ Influenza Frankenviruses: Journal ‘npj Vaccines’

November 28, 2025

Read full story

NIAID Funds Creation of Chimeric H5N1 Bird Flu Viruses With Modified Cleavage Sites and Enhanced Mammalian-Cell Expression: ‘npj Vaccines’

November 29, 2025

Read full story

Trump Admin Doubles Down on EO Exemptions for Gain-of-Function Experiments: Journal ‘Nature Medicine’

Jan 17

Read full story

WHO Vows ‘There Will Be Influenza Pandemics in the Future’

Jan 22

Read full story

‘Critical Loophole’ in U.S. Biosecurity Rules Allows Legal Assembly of 1918 Spanish Flu Pandemic Virus DNA: Journal ‘Nature Communications’

Jan 16

Read full story

U.S. Military Funds Intranasal Spray Self-Replicating sa-mRNA H5N1 Bird Flu Vaccine Built From Chimeric Viral Constructs: Journal ‘Nature Communications’

Jan 15

Read full story

Portugal Runs H5N1 Bird Flu Outbreak Simulation—Echoing Pre-COVID Pandemic Exercises

Jan 13

Read full story

DARPA Uses AI to Push Viral Pandemic Outbreak Modeling From Weeks to Days

Jan 9

Read full story

Bill Gates’ CEPI Revives Moderna mRNA Bird Flu Vaccine Development With $54M Investment After HHS Terminated Funding

December 19, 2025

Read full story

Saudi Arabia Bets on 2026 Bird Flu Pandemic, Ramps Up Domestic Vaccine Production Amid International H5N1 Gain-of-Function Fears

October 30, 2025

Read full story

*Article credits Jon Fleetwood

WHO Vows ‘There Will Be Influenza Pandemics in the Future’. Imagine That.

Public health forecasting—or orchestration?

On Wednesday, the World Health Organization (WHO) published an influenza fact sheet in which it declared that influenza pandemics are on the horizon, emphasizing bird flu.

In a document titled “Influenza (avian and other zoonotic),” the WHO did not say that it thinks an influenza pandemic is coming.

It did not say a future pandemic is a possibility.

The unelected foreign organization stated its coming is a fact, writing:

There will be influenza pandemics in the future, but when and with which virus, as well as where and how they will spread, is difficult to predict. They can have significant health, economic and social consequences. An influenza pandemic arises when an influenza virus emerges with the ability to cause sustained human-to-human transmission, and the human population has little to no immunity against the virus.

Whether currently circulating avian, swine and other influenza viruses will result in a future pandemic is unknown. However, the diversity of zoonotic influenza viruses that have caused human infections necessitates strengthened surveillance in both animal and human populations, thorough investigation of every zoonotic infection and pandemic preparedness planning.

The WHO financially benefits from pandemics.

The org received approximately $7.9 billion in total funding during the 2020-2021 biennium, exceeding its $5.84 billion approved budget by 36% due to massive COVID-19 emergency contributions.

Of this, around $3 billion was specifically for COVID-19 operations, marking an unprecedented surge from pre-pandemic levels.

A top contributor to the WHO is Bill Gates, who recently—through his Coalition for Epidemic Preparedness Innovations (CEPI)—invested $54.3 million to support Moderna’s new mRNA-based pandemic H5 avian influenza “bird flu” vaccine candidate, mRNA-1018.

Gates also financially backs biolabs said to be performing gain-of-function experiments on bird flu pathogens.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

The Gates Foundation and HHS have also been funding experiments said to be deliberately infecting American adults with a lab-grown pandemic influenza virus at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

If the WHO’s pandemic warnings are being issued inside a funding ecosystem that profits from crisis response—while those same donors bankroll laboratories now linked by governments to pandemic creation and fund programs that deliberately infect Americans with lab-grown influenza—then the line between public health forecasting and systemic orchestration is no longer defensible.

NIAID, DARPA, Bill Gates Intentionally Infect 80 Americans With Lab-Made Pandemic Influenza Virus: HHS Study

October 13, 2025

Read full story

Bill Gates’ CEPI Revives Moderna mRNA Bird Flu Vaccine Development With $54M Investment After HHS Terminated Funding

December 19, 2025

Read full story

WHO Instructs Governments to Track Online Anti-Vaccine Messaging in Real Time with AI: Journal ‘Vaccines’

December 29, 2025

Read full story

WHO Demands 90,000 Influenza and COVID PCR Tests Per Month Worldwide, Spanning 153 Labs in 131 Countries, Including U.S. CDC

December 23, 2025

Read full story

How the WHO Dictated the COVID-19 Pandemic—And How It’s Already Dictating the Coming Bird Flu Pandemic

December 10, 2025

Read full story

‘All Governance Functions Assumed by a Single Entity’: WHO-Backed Influenza Framework Outlines Command Merger During Next Pandemic

December 9, 2025

Read full story

WHO Rolls Out ‘Future’ COVID Pandemic Plan Using U.S. Labs for ‘Global Sentinel Surveillance’—Even After Trump Ordered Withdrawal

December 3, 2025

Read full story

WHO–Gates Blueprint for Global Digital ID, AI-Driven Surveillance, and Life-Long Vaccine Tracking for Every Person

December 2, 2025

Read full story

WHO Deploys National Pandemic Influenza Surveillance Grid in Egypt—270 Officers Trained for Real-Time Monitoring Across 30 Sentinel Sites

November 24, 2025

Read full story

WHO, CDC, Gates, and Oxford Were Used to Test Public ‘Compliance’ Strategies for ‘Lower-Quality Vaccines’ Before Any COVID-19 Jabs Existed: ‘PLOS Glob Public Health’ Journal

November 23, 2025

Read full story

WHO Builds International Pandemic Command System Through New Pathogen-Sharing Agreement

November 10, 2025

Read full story

Bird Flu Research Explodes 1,000% Worldwide—WHO, CDC, and EcoHealth Lead Rapid Expansion: ‘Journal of Infection and Public Health’

November 3, 2025

Read full story

WHO Quietly Reactivates Global Influenza Pandemic Apparatus for Bird Flu: ‘Journal of Infectious Diseases’

October 18, 2025

Read full story

WHO Runs 2-Day Pandemic Simulation: ‘Exercise Polaris’

April 8, 2025

Read full story

Trump’s CDC, FDA ‘Actively Participating’ in WHO Bird Flu Seminar Despite Executive Order to Withdraw U.S. from International Organization: STAT

February 25, 2025

Read full story

Gates Pours $3.3M Into mRNA Purification Tech—Admitting COVID Vaccine Impurity Problem as Platform Becomes Permanent

December 17, 2025

Read full story

Gates Holds $254 Million in Big Oil Investments Despite Blaming the Industry for ‘Climate Change’

Jan 21

Read full story

*Article credits Jon Fleetwood

Texas Air-Drops Live Virus-Containing Edible Rabies Vaccines Over Cities from Aircraft—’Leaving Persons at Risk for Vaccine Exposure and Vaccine Virus Infection’ Uninformed and with No Consents: CDC

Animals that ingest the oral vaccine are said to be contagious to other animals and humans for over a month.

On January 6, 2012, Brig. Gen. William L. Smith, Director Joint Staff and Commander, Domestic Operations for Joint Force Headquarters of Texas (second from left) met with members of the Texas State Guard and received an overview of the annual Texas Oral Rabies Vaccination Program in Zapata, Texas. Since the program’s inception in 1995, more than 39 million doses of the oral rabies vaccine, Raboral V RG, have been distributed over approximately 540,000 square miles of Texas. (U.S. Army Photo photo by Laura L. Lopez/Wikimedia Commons).

The Texas Department of Health and Human Services (DHS) has begun its annual distribution of RABORAL V-RG®, an oral rabies vaccine (ORV) bait—dropping the live laboratory-made virus from airplanes over Texas, as well as distributing it by hand.

The $2 million annual project is funded by the State of Texas and the United States Department of Agriculture Animal and Plant Health Inspection Service/Wildlife Services.

The U.S. Centers for Disease Control and Prevention (CDC) has known for over a decade that the RABORAL edible vaccine leaves “persons at risk for vaccine exposure and vaccine virus infection.”

Yet the department still allows millions of live genetically modified virus baits to be dispersed over communities, forests, and waterways each year without public notice, informed consent, or comprehensive biosafety oversight—posing potential risks to human health, wildlife, and national biosecurity.

Americans are being involuntarily exposed to laboratory-engineered pathogens capable of infecting multiple species, with no transparent risk disclosure or opt-out mechanism.

A DHS press release reads:

Texas Department of State of Health Services will expand anti-rabies efforts around the El Paso area in January during the agency’s 32nd annual Oral Rabies Vaccination Program. Aerial bait distribution, which occurs along much of the Texas-Mexico border, was increased last year to include far West Texas as a response to the Arizona Fox rabies variant that is now established in New Mexico and within 150 miles of the Texas border.

In addition to those continued flights this year, rabies vaccine baits will also be distributed by hand in targeted areas around the city.

The rabies vaccine bait air drop will begin with flights from Alpine on Jan. 16, with additional flights slated to originate from Del Rio International Airport on Jan. 21, weather permitting. The vaccine bait, manufactured by Boehringer Ingelheim Animal Health USA Inc., is enclosed in a small plastic packet (similar to a fast-food ketchup package) dipped in fish oil and fish-meal crumbles to attract wild canids, like coyotes and foxes.

Between six and nine flights are scheduled per day during the two-week operation, with airdrop aircraft flying at 500 to 1,000 feet above ground level and dropping roughly 693,600 oral rabies vaccine baits at 50 baits per square mile. ORVP’s Border Maintenance Zone includes 19 Texas counties including El Paso, Hudspeth, Culberson, Jeff Davis, Presidio, Brewster, Pecos, Terrell, Val Verde, Kinney, Maverick, Zavala, Dimmit, Webb, Zapata, Starr, Hidalgo, Cameron and Willacy.

In addition to the hand-distribution efforts in the El Paso area, baits will also be distributed by hand in parts of Cameron, Hidalgo, Starr and Willacy counties.

The U.S. Department of Agriculture warns humans “should leave [the live-virus containing edible vaccine] undisturbed if they are encountered.”

• If people come in contact with the bait, “they should immediately wash the contact area with warm water and soap.”
• Dogs that consume the bait “may experience a temporary upset stomach.”

A July 2019 peer-reviewed study in Vaccineconfirms the RABORAL oral rabies vaccine:

• is a genetically engineered chimeric “Frankenstein” human virus expressing a rabies gene,
• sheds for weeks in multiple species,
• was not tested for live virus persistence,
• can potentially infect non-target animals and humans,
• and was studied by researchers financially tied to its sale.

Most alarmingly, the study confirmed that virus DNA from the edible vaccine can be detected in both oral and rectal swabs post-inoculation in most animals, “followed by a resurgence of shedding between days 17 and 34 in some species.”

This means animals that ingest the oral vaccine are said to be contagious to other animals and humans for over a month.

On January 6, 2012, Texas State Guard member, Private Paul Pettit of the 3rd Battalion, 1st Regiment takes part in one of the many flights that assists in the aerial distribution of Raboral V RG, during a 10-day Oral Rabies Vaccination Program. With statistics showing a drastic reduction in rabies cases the goal of this program is to create zones of vaccinated coyotes and gray foxes along the leading edges of the epizootics stopping the spread of the virus. (U.S. Army photo by Laura L. Lopez/Wikimedia Commons).

A September 2017 Veterinary Research publication confirms that the live virus in RABORAL edible vaccines actively replicates in animals after ingestion, that horizontal transmission of the vaccine virus between animals has occurred, and that humans have been infected with vaccine-derived vaccinia following bait exposure.

The same study shows that RABORAL baits deliberately disperse tetracycline—a toxic ingredient in the vaccine—into the environment as a biomarker, where it accumulates in animal bone and teeth, can misrepresent true vaccination, and is acknowledged to carry potential ecotoxicity and antimicrobial-resistance risks with long-term use.

In the name of “wildlife management,” Texas authorities are blanketing cities with what are said to be live virus-containing packets without full public consent.

How many Texans have been informed that they are living inside an ongoing, state- and federally funded environmental release of a live, laboratory-engineered virus documented to replicate, spread between animals, persist in bodily secretions, and infect humans—without informed consent or any meaningful ability to refuse exposure?

USDA Drops Live Virus-Containing Rabies Edibles from Helicopters, Airplanes Across United States—’Leaving Persons at Risk for Vaccine Exposure and Vaccine Virus Infection’: CDC

October 16, 2025

Drones Spray ‘Self-Spreading’ COVID-19 Vaccine for ‘Large-Area Inoculation of Humans’ in ‘DEFUSE’ EcoHealth/DARPA Project

December 24, 2024

Operation ‘Large Area Coverage’ (LAC): U.S. Gov’t Covertly Sprays Airborne Toxic Chemical Agent on Unsuspecting Americans in Secret Bioweapons Experiment

October 31, 2024

‘Operation Sea-Spray’: U.S. Gov’t Secretly Sprays Deadly Bacteria Cloud on Americans in Bioweapons Experiment

January 3, 2025

Read full story

PREP Act Empowers Gov’t to ‘Administer’ Drugs, Biological Products, Devices to Citizens in Secret

December 31, 2024

Read full story

CDC, NIAID, DARPA Infect 36 People with Lab-Made Epidemic Influenza Virus: Journal ‘Influenza and Other Respiratory Viruses’

October 14, 2025

Read full story

NIAID, DARPA, Bill Gates Intentionally Infect 80 Americans With Lab-Made Pandemic Influenza Virus: HHS Study

October 13, 2025

Read full story

American Bioweapons: Then & Now

May 29, 2024

Read full story

Investigation Into U.S. Military Bioweapons-Origin of Tick-Borne Lyme Disease Successfully Added to 2026 National Defense Authorization Act

December 12, 2025

Read full story

Over 100 ‘BSL-4’ Bioweapons Labs Now Operate Worldwide, with More Under Construction: ‘Journal of Public Health’

October 23, 2025

Read full story

Measles Vaccine and Gain-of-Function: The Inconvenient Truth About CD150/CD46 Tropism Shift

March 5, 2025

Read full story

Texas Gave 15,000 More MMR Shots This Year—Now It Has More Measles Cases Than the Entire U.S. Had in 2024

March 25, 2025

Read full story

Free Measles Vaccine Campaign Followed by Measles Outbreak in Texas County

February 17, 2025

Read full story

*Article credits by Jon Fleetwood

U.S. Military Funds Intranasal Spray Self-Replicating sa-mRNA H5N1 Bird Flu Vaccine Built From Chimeric Viral Constructs: Journal ‘Nature Communications’

U.S. government is not slowing its push toward intranasal self-replicating RNA vaccine technology.

A U.S. military–funded research program has developed an intranasal, self-replicating RNA (sa-mRNA) vaccine targeting H5N1 avian influenza, built using chimeric viral constructs assembled through reverse genetics.

The work was disclosed in a 2026 Nature Communications paper and explicitly funded through a U.S. Army–administered biodefense contracting mechanism.

The vaccine is said to force cells to produce H5N1 bird flu antigen while simultaneously producing viral replication enzymes that copy the self-amplifying RNA inside the cell.

The U.S. government is funding the creation of next-generation bird flu vaccines while funding the creation of purported chimeric “Frankenstein” bird flu viruses.

Congress, the White House, the Department of Energy, the FBI, the CIA, and Germany’s Federal Intelligence Service (BND) have confirmed that the COVID-19 pandemic was likely the result of lab-engineered pathogen manipulation.

Why is the government making the bird flu pandemic problem and solution at the same time, just like it was doing with coronaviruses before the COVID-19 outbreak?

---

What Was Built

The researchers are said to have engineered a self-amplifying RNA vaccine that uses a Venezuelan equine encephalitis virus (VEEV) replicon backbone into which they inserted influenza hemagglutinin (HA) genes from H5N1 (and H7N9).

The RNA construct was packaged in a cationic nanostructured lipid carrier and designed for intranasal spray delivery.

This is not conventional mRNA.

Self-amplifying RNA replicates inside host cells, increasing antigen production after administration.

While the construct is described as replication-defective (it lacks viral structural genes and cannot form a spreading virus), it is nonetheless a synthetic viral system built from components of different viruses.

Reverse Genetics & Chimeric Design

The platform was produced using reverse genetics—starting from gene sequences, cloning them into plasmids, and generating RNA by in-vitro transcription.

In practical terms, this means influenza genetic material was deliberately engineered into a VEEV replicon, creating a chimeric viral construct designed to self-amplify once inside cells.

This approach represents intentional genetic assembly of viral parts to achieve a specific biological effect.

Intranasal Spray Delivery

The vaccine was purpose-built for intranasal (IN) administration, a route the authors emphasize for inducing mucosal and lung-resident immune responses that intramuscular vaccines do not generate.

The paper reports distribution throughout the upper and lower respiratory tract, with some material swallowed into the gastrointestinal tract—a confessed feature of intranasal dosing.

This delivery choice matters because it places a self-replicating RNA system directly onto respiratory mucosa, rather than confining it to muscle tissue.

The Virus Target: H5N1

The primary antigen target is H5N1 avian influenza, repeatedly framed in the paper as a pre-pandemic threat.

Ferret challenge experiments involved high-dose intranasal exposure to influenza, with the sa-mRNA platform reported to protect against severe disease.

The study positions the platform as rapidly deployable, emphasizing scalability, thermostability, and potential for stockpiling—language consistent with pandemic preparedness, not routine seasonal vaccination.

Who Funded It—& How

The paper states plainly that the work was “sponsored by the US Government under Other Transaction number W15QKN-16-9-1002.”

W15QKN-16-9-1002 is a U.S. Army Contracting Command–New Jersey Other Transaction Agreement (OTA) established under Section 815 of the 2016 National Defense Authorization Act.

The agreement created the Medical CBRN Defense Consortium (MCDC) to fund research and development of medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats.

Key points from the OTA itself:

• The agreement is administered by the U.S. Army Contracting Command on behalf of the Department of Defense.
• It authorizes the government to select, direct, and fund specific projects it deems necessary.
• The scope explicitly includes vaccines, medical countermeasures, and manufacturing platforms designed for rapid response to biological threats.
• The estimated value of projects issued under the agreement is up to $10 billion, with a 20-year term.

The research was supported through a military biodefense R&D framework designed to develop deployable medical technologies.

Bottom Line

The Nature paper confirms that a U.S. military–administered funding program supported the development of an intranasal, spray-form self-replicating sa-mRNA vaccine built from chimeric viral constructs that include H5N1 influenza genes.

The authors emphasize speed, scalability, and deployment readiness.

This is best understood not as a routine flu-vaccine study, but as a biodefense-driven platform demonstration: a synthetic, self-amplifying viral system designed for rapid respiratory deployment in a future pandemic scenario.

At a time when governments now acknowledge that lab-engineered pathogens can spark global crises, the United States is simultaneously funding the creation of chimeric avian influenza systems and the intranasal self-replicating technologies positioned to counter them—collapsing the line between pandemic threat creation and pandemic response into the same military-run pipeline.